Sankey It
Loading...
Eli Lilly and Company FY2022 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company FY2022 income statement
USD · fiscal year ended 2022-12-31
FY2025
FY2024
FY2023
FY2022
FY2021
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company FY2022 income statement
Flow diagram with 10 nodes and 9 flows for Eli Lilly and Company FY2022 income statement. Values: Product US$25.5B, Collaboration and Other Revenue US$3.1B, Revenue US$28.5B, Cost of Revenue US$6.6B, Gross Profit US$21.9B, Operating Expenses US$13.3B, Operating Income US$8.7B, Other Expense US$1.8B, Tax US$561.6M, Net Income US$6.2B.
Product
US$25.5B
-2% Y/Y
89% of revenue
Collaboration and Other Revenue
US$3.1B
+30% Y/Y
11% of revenue
Revenue
US$28.5B
+1% Y/Y
Cost of Revenue
(US$6.6B)
-9% Y/Y
23% of revenue
Gross Profit
US$21.9B
+4% Y/Y
77% margin
Operating Expenses
(US$13.3B)
+1% Y/Y
46% of revenue
Operating Income
US$8.7B
+9% Y/Y
30% margin
Other Expense
(US$1.8B)
+4% Y/Y
6% of revenue
Tax
(US$561.6M)
-2% Y/Y
2% of revenue
Net Income
US$6.2B
+12% Y/Y
22% margin
Net / profit
Inputs
Tax / cost
Copy link
Share on X
Open full screen